Blood Pressure Drug Recalled Nationwide: Tablets May Not Dissolve Properly
Key Points:
- A generic high blood pressure medication containing olmesartan medoxomil, amlodipine, and hydrochlorothiazide has been recalled nationwide due to tablets potentially not dissolving properly, which may reduce their effectiveness.
- The recall, classified as a class II event by the FDA, indicates the medication could cause temporary or reversible health issues, but serious complications are unlikely.
- The recall involves two lots of the drug distributed by Macleods Pharma, including about 3,500 bottles of 30-count and 200 bottles of 90-count, all expiring on May 31, 2027.
- Patients are advised not to stop taking the medication without consulting their healthcare provider or pharmacist, as continued use is generally recommended unless otherwise instructed.
- The FDA and Everyday Health emphasize contacting a healthcare professional if there are concerns regarding the recalled medication to ensure safe management of high blood pressure.